PS
ABBV icon

Pinney & Scofield’s AbbVie ABBV Stock Holding History

Pinney & Scofield’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Hold
478
– – 0.06% 75
2026
Q1 		$104K Hold
478
– – 0.06% 78
2025
Q4 		$109K Sell
478
-10
-2% -$2.28K 0.06% 75
2025
Q3 		$113K Hold
488
– – 0.07% 70
2025
Q2 		$90.6K Buy
488
+288
+144% +$53.5K 0.06% 78
2025
Q1 		$41.9K Hold
200
– – 0.03% 106
2024
Q4 		$35.5K Buy
+200
New +$36.8K 0.03% 112

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pinney & Scofield's ABBV Position: Q2 2026 in Review

Pinney & Scofield held its AbbVie (ABBV) position steady in Q2 2026 at 478 shares worth $120K. The position accounts for 0.06% of the portfolio, ranked #75.

Pinney & Scofield first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pinney & Scofield held 478 shares of AbbVie worth $120K as of Q2 2026.
  • Pinney & Scofield left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.06% of Pinney & Scofield's portfolio in Q2 2026, its #75 holding.
  • Pinney & Scofield first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pinney & Scofield's 13F filing for Q2 2026, filed 7 Aug 2026.